Role of cytokines and platelet-activating factor in microvascular immune injury.

scientific article

Role of cytokines and platelet-activating factor in microvascular immune injury. is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1159/000234755
P698PubMed publication ID2651321

P2093author name stringP Braquet
D Hosford
F Bussolino
R Bourgain
M Braquet
P433issue1-2
P921main subjectmicrovesselQ6840468
P304page(s)88-100
P577publication date1989-01-01
P1433published inInternational Archives of Allergy and Applied ImmunologyQ26839570
P1476titleRole of cytokines and platelet-activating factor in microvascular immune injury
P478volume88

Reverse relations

cites work (P2860)
Q34784452A search for an animal model of the Spanish toxic oil syndrome
Q45084608Blood-brain barrier changes following intracerebral injection of human recombinant tumor necrosis factor-alpha in the rat.
Q73957904Cardiac depression and cellular injury in hemorrhagic shock and reinfusion: role of free radicals
Q33613125Cardiac release of chemoattractants after ischaemia induced by coronary balloon angioplasty
Q43205565Changes and Relationship of PAF and TNF in Rats with Myocardial Ischaemia and Reperfusion Injury
Q36631639Cytokine production by human colonic intraepithelial lymphocytes in controls and ulcerative colitis
Q55067142Dietary flax seed in prevention of hypercholesterolemic atherosclerosis.
Q34792443Differential effects of the PAF receptor antagonist UK-74,505 on neutrophil and eosinophil accumulation in guinea-pig skin.
Q45077050Endothelin-induced intracellular Ca2+mobilization through its specific receptors in murine peritoneal macrophages
Q36608456Flaxseed.
Q34981878Gender dimorphism in immune responses following trauma and hemorrhage
Q44894791Histopathological effects of intracerebral injections of human recombinant tumor necrosis factor-? in the rat
Q28369591In vitro modulation of interleukin-1 beta secretion by cultured rat doxorubicin-stimulated whole glomeruli and dissociated mesangial glomerular cells
Q41935842Inverse Association between Cardiac Troponin-I and Soluble Receptor for Advanced Glycation End Products in Patients with Non-ST-Segment Elevation Myocardial Infarction
Q37057900Involvement of platelet-activating factor (PAF) in septic shock and priming as indicated by the effect of hetrazepinoic PAF antagonists
Q43111872Lipoxygenase metabolites modulate vascular-derived platelet activating factor production following endotoxin challenge
Q47988346Markedly elevated levels of inflammatory cytokines in maternal serum and peritoneal washing during arrested labor
Q24679901Neurology of the vasculitides and connective tissue diseases
Q34452521Oxidative stress as a mechanism of added sugar-induced cardiovascular disease
Q74171219Oxidative stress as a mechanism of diabetes in diabetic BB prone rats: effect of secoisolariciresinol diglucoside (SDG)
Q42942095P-selectin and platelet-activating factor mediate initial endotoxin-induced neutropenia
Q28609461PAF. A review of its effects, antagonists and possible future clinical implications (Part II)
Q36065338Pathophysiology and Medical Treatment of Carotid Artery Stenosis
Q67665540Platelet activating factor does not release histamine from human dispersed cutaneous mast cells
Q40521630Platelet-activating factor and the cytokine network in inflammatory processes
Q37057794Platelet-activating factor in cardiovascular stress situations
Q71645088Potentiation of histamine release from human leucocytes by PAF
Q73853387Protective effect of secoisolariciresinol diglucoside against streptozotocin-induced diabetes and its mechanism
Q38523267Role of Advanced Glycation End Products and Its Receptors in the Pathogenesis of Cigarette Smoke-Induced Cardiovascular Disease
Q54589893Role of platelet-activating factor in pathogenesis of galactosamine-lipopolysaccharide-induced liver injury.
Q68297075Synergistic effect of throm☐ane A2 and N-formylmethionylleucylphenylalanine on platelet-activating factor synthesis in human polymorphonuclear neutrophils
Q41625286Systemic treatment with murine recombinant interleukin-1 beta inhibits the growth and progression of malignant glioma in the rat.
Q71195538The pathogenesis of septic shock
Q74623601The role of platelet-activating factor in cell infiltration in endotoxin-induced uveitis in guinea pigs
Q28081511The role of platelet-activating factor in mesangial pathophysiology
Q67494311Vasculitic neuropathy

Search more.